Clinical Benefits and Safety of Multiple Micronutrient Supplementation During Preconception, Pregnancy, and Lactation: A Review
Nutrition Reviews · 2025
DOI: 10.1093/nutrit/nuaf079 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Nutrition Reviews, 2025. Verfasst von Jue Liu und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Regulatory, Medical, Safety, Quality & Compliance (RMSQC), Bayer Healthcare Company Limited, 200126 Shanghai, China. Hauptthemen laut MEDLINE: Dietary Supplements, Lactation, Micronutrients, Preconception Care. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 129 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Bayer employees, Bayer Healthcare Company Limited, Bayer.
Themen: Stillen
Abstract (Originalsprache)
Objective
In this review we sought to determine the clinical benefits and safety of a multiple micronutrient supplement/supplementation (MMS) throughout preconception, pregnancy, and lactation in the mother and their child.
Background
No guidelines for pregnancy specifically recommend supplementation with micronutrients other than folic acid and iron or continuing the use of MMS beyond the first trimester. Yet micronutrients are essential during all stages of pregnancy for healthy fetal growth and development and maternal health, with an increased intake of many micronutrients recommended during pregnancy and lactation. The MMS reviewed (Elevit, Bayer) is the most studied prenatal form of MMS, supported by 30 publications reporting studies conducted worldwide over 30 years and used by millions of women over a period of 40 years. Until now, the data have not yet been consolidated.
Methods
We performed a literature search to identify published studies for trials that used MMS at any stage of the pregnancy journey.
Results
Outcomes reported in 30 trials suggested that MMS improves micronutrient status, leads to a healthier reproductive environment during preconception, and can significantly reduce neural tube defects and congenital abnormalities in early pregnancy above and beyond supplementation with folic acid alone. We also found that MMS can reduce adverse pregnancy outcomes during the second and third trimesters, including miscarriage, pre-eclampsia, anemia, preterm birth, and placental insufficiency, and improve docosahexaenoic acid status. In addition, MMS improves the quality of breastmilk and reduces postpartum depression. Using MMS containing 800 μg folic acid is more effective than supplementing with 400 μg folic acid alone. Very few adverse events were reported in infants, almost all of which were considered unrelated to MMS intake. In one cohort, periconceptual MMS in children was linked to higher rates of otitis media and atopic dermatitis than placebo, but these results may be partly attributed to multiple hypothesis testing and differences in family history, respectively.
Conclusion
Improving micronutrient status with MMS in women who are trying to conceive, pregnant, or breastfeeding may have beneficial effects on fertility, the integrity of the embryonic environment, development of the embryonic brain and nervous system, and the growth, development, and long-term health of the child.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Regulatory, Medical, Safety, Quality & Compliance (RMSQC), Bayer Healthcare Company Limited, 200126 Shanghai, China.
- Department of Regulatory, Medical, Safety, Quality & Compliance (RMSQC), Bayer Consumer Care AG, 4052 Basel, Switzerland.
- UMAE HGO4 Luis Castelazo Ayala, Tizapan San Ángel, 01090 Mexico City, Mexico.
- FRCCSC RAS - Federal Research Center Computer Sciences and Control Russian Academy of Sciences, 119333 Moscow, Russian Federation.
- Sugiyama Clinic Marunouchi, Center for Reproductive Medicine and Endoscopy, Tokyo, 100-0005, Japan.
- Department of Obstetrics and Gynecology, the First Affiliated Hospital of Chongqing Medical University, 400016 Chongqing, China.
ORCID-Profile: Keiji Kuroda
Förderung
- Bayer employees
- Bayer Healthcare Company Limited
- Bayer
Zitieren
APA
Liu, J., Mantantzis, K., Kaufmann, L., Campos Goenaga, Z., Gromova, O., Kuroda, K., Qi, H., Tetruashvili, N., & Di Renzo, G. C. (2025). Clinical Benefits and Safety of Multiple Micronutrient Supplementation During Preconception, Pregnancy, and Lactation: A Review. Nutrition Reviews. https://doi.org/10.1093/nutrit/nuaf079
Vancouver
Liu J, Mantantzis K, Kaufmann L, Campos Goenaga Z, Gromova O, Kuroda K, et al. Clinical Benefits and Safety of Multiple Micronutrient Supplementation During Preconception, Pregnancy, and Lactation: A Review. Nutrition Reviews. 2025. doi:10.1093/nutrit/nuaf079
BibTeX
@article{Liu2025,
author = {Liu, Jue and Mantantzis, Konstantinos and Kaufmann, Ligaya and Campos Goenaga, Zigor and Gromova, Olga and Kuroda, Keiji and Qi, Hongbo and Tetruashvili, Nana and Di Renzo, Gian Carlo},
title = {Clinical Benefits and Safety of Multiple Micronutrient Supplementation During Preconception, Pregnancy, and Lactation: A Review},
journal = {Nutrition Reviews},
year = {2025},
doi = {10.1093/nutrit/nuaf079}
}
EUVIMED